Theft prevention and security devices, namely cable locks, electronic sensors, locking device to be placed around the neck and lip or cap of a bottle to prevent the theft of the bottle or its content, hard tags, both alarming and non-alarming; alarming and non-alarming display fixtures to provide security against theft at retail stores, and lockable storage and display containers, both alarming and non-alarming, media security containers for DVD’s, cassettes, CD’s, video tapes, game cartridges and disks, both alarming and non-alarming, to prevent theft of merchandise in retail stores.

Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video in the field of Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media, namely CDs, DVDs, thumb drives and video tapes in the field of Alpha-1 Antitrypsin Deficiency; printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency

Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes

Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video in the field of Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media, namely CDs, DVDs, thumb drives and video tapes; printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency

Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes

Downloadable electronic publications in the nature of informational and educational materials, namely newsletters, in the field of Alpha-1 Antitrypsin Deficiency; printed informational and educational materials, namely, newsletters, in the field of Alpha-1 Antitrypsin Deficiency.

Cellular telephones.

Telecommunications services, namely, wireless voice and data transmission, two way wireless transmission of email and text between wireless telecommunication terminals and computers, and providing multiple-user access to a global computer network.

Surgical and medical apparatus and instruments in the nature of orthopaedic correction, adjustment and pain relief devices for feet; orthopaedic articles, namely splints and bandages alone and in combination; orthopaedic footwear; orthopaedic soles, artificial limbs; footwear, namely, shoes, sandals, flip-flops, socks and bandages for feet; gloves, namely, orthopaedic gloves in the nature of orthopaedic correction devices for hands, sporting gloves and household gloves for general use.

Medical assistance, namely medical consultation and diagnostic services and chiropractic services.

Normal alpha olefin used in the manufacture of products such as polyethylene, alpha olefin sulphonates, linear alkyl benzene sulphonate, polyalphaolefins, candles, PVC lubricants, personal care products, drilling fluids, metalworking fluids, flavors, fragrances, metal alkyls, alkyl silanes, mercaptans, epoxides, alkenyl succinic anhydride, lube oil additives, polyol esters, alkyl aromatics, detergent alcohols, and maleic anhydride copolymers.

Cosmetics, namely, skin creams, lotions.

Application service provider (ASP) services featuring software in the field of financial services for managing risk and investment information; providing financial information in the field of investment funds; providing temporary use of software by means of the Internet for managing risk and information in the field of investments.